Lectin histochemistry of the rat brain following thioacetamide-induced hepatic failure

Biotinyl derivatives of several lectins were used to study the localization of glycoconjugates in the cerebral microcapillaries and various brains of rats given at 24-h intervals two ip administrations of a hepatotoxin-thioacetamide (TAA) and examined 21 d posttreatment. At this time, the rats were asymptomatic with regard to hepatic encephalopathy but showed specific and selective changes in the blood-brain-barrier (BBB) transport of basic amino acid, but no BBB damage, and region-specific neuronal injury in the hippocampus and neocortex. The lectins tested recognized the following sugar residues: β-d-galactosyl (Ricinus communis agglutinin [RCA-1]);N-acetyl-glucosaminyl andN-acetyl-neuraminic acid (wheat-germ agglutinin [WGA]);N-acetyl-d-galactosaminyl (Helix pomatia agglutinin [HPA]); β-d-galactosyl andd-galactosyl neuraminic acid (peanut agglutinin [PNA]), and α-d-galactosyl and α-d-mannosyl (concanavalin A [Con A]). The treatment markedly decreased the binding to the cerebromicrovascular network of the hippocampus and neocortex of RCA-1 and WGA. The binding of these two lectins to their complementary monosaccharide residues appears to reflect subtle changes in BBB function, with a detection threshold below the conventional BBB permeability tests. The changes in the binding of the other two lectins: an increase of HPA binding and a decrease of Con A binding, confined to neocortical neurons and pyramidal cells of hippocampus injured by TAA treatment.     

实验性帕金森病纹状体、大脑皮质、海马组织Glu含量的变化

目的:探索帕金森病(PD)的发病机制。方法:应用大鼠选择性偏侧(右侧)PD动物模型,观测正常对照组,PD组(造模后2周)左右侧纹状体(ST)、大脑皮质(CC)、海马(HP)组织谷氨酸(Glu)含量的变化。结果:PD组右侧ST、CC、HP组织Glu含量显著低于左侧和正常对照组左右侧(P<0.01);PD组左侧ST、CC、HP组织Glu含量与正常对照组比较无显著差异性(P>0.05);正常对照组左右侧ST、CC、HP组织Glu含量无显著差异性(P>0.05)。结论:神经递质Glu参于PD累及部位ST、CC、HP损伤的发病机制     

Effects of GTP on hormone-stimulated adenylate cyclase activity in cerebral cortex, striatum, and hippocampus from rats treated chronically with lithium

The effects of lithium on guanosine triphosphate (GTP) stimulated adenylate cyclase activity and hormone-induced GTP activation of the enzyme have been studied in three regions of the rat brain. Chronic treatment with lithium, giving a serum lithium level of 0.71 +/- 24 mmol/L, reduced isoprenaline-induced GTP stimulation of adenylate cyclase activity in cortical membranes at concentrations of GTP up to 2 microM. No effect of lithium was observed at higher concentrations of GTP. The enzyme activity stimulated by GTP alone was unaltered by lithium ex vivo. In striatal membranes, lithium ex vivo decreased both dopamine-induced GTP activation of adenylate cyclase and GTP-stimulated adenylate cyclase activity at concentrations of GTP below 2 microM. No effects of lithium ex vivo were found in striatum at 2 microM GTP and above. In hippocampal membranes, lithium ex vivo did not influence either serotonin-induced GTP stimulation of the adenylate cyclase or GTP-stimulated enzyme activity at low levels of GTP. However, at 50 microM GTP, lithium ex vivo enhanced serotonin-stimulated enzyme activity. The present results suggest that lithium ex vivo decreases neurotransmitter activation of the cortical beta-adrenergic adenylate cyclase by influencing the mechanisms by which receptor agonists enhance the GTP stimulation of the adenylate cyclase. Furthermore, lithium ex vivo exerts a region-specific action on the brain adenylate cyclases, but in the brain regions studied, an effect of lithium on N-protein level might be of significance for the action of lithium ex vivo on neurotransmitter activation.     

Cellular composition of primary cultures from cerebral cortex, striatum, hippocampus, brainstem and cerebellum

Primary cultures from newborn rat cerebral cortex, striatum, hippocampus, brainstem and cerebellum were grown for 14 days. There was a linear relationship between the amount of material seeded and the protein content of the respective culture. The amount of tissue material seeded was selected so that the different cultures reached confluence at 6-7 days and contained similar amounts of protein when 7 and 14 days old. The cellular content was evaluated by astroglial markers, such as the glial fibrillary acidic protein (GFAp; alpha-albumin) and the S-100 protein, and by markers for other cells expected to be in the cultures (14-3-2 protein, macrophage acidic protein (MAP), alkaline phosphatase, myelin basic protein (MBP), 2',3'-cyclic nucleotide 3'-phosphohydrolase (CNP]. Astroglial-like cells represented 60-70% of the cells present in the different cultures. Quantitation of GFAp (alpha-albumin) showed similar amounts to be present in cultures from cerebral cortex, hippocampus and striatum; however, on lower levels expressed in soluble proteins than in the corresponding brain regions of adult rats. Brainstem of adult rat contained large amounts of GFAp (alpha-albumin), while low levels were found in brainstem culture. Also, phagocytic cells (macrophages), endothelial-like cells, mesenchymal-like cells, ependymal-like cells and oligoblasts were found. Neither mature neurons, nor oligodendroglial cells were observed. It is concluded that although there might be some differences in the degree of maturation or in the cellular composition of the various cultures, they could serve as a good model system for studying the characteristics of astroglial cells from various brain regions.     

Effects of insulin-induced hypoglycemia on somatostatin level and binding in rat cerebral cortex and hippocampus

The effects of severe insulin-induced hypoglycemia on somatostatin level and specific binding in the cerebral cortex and hippocampus were examined using 125I-Tyr11-somatostatin as a ligand. Severe insulin-induced hypoglycemia did not affect the level of somatostatin-like immunoreactivity in the brain areas studied. However, the number (but not the affinity) of specific somatostatin receptors was significantly decreased in membrane preparation from the hippocampus but not in the cerebral cortex at the onset of hypoglycemic coma (5-10 min). Administration of glucose at the onset of hypoglycemic coma brought about extensive recovery of hippocampal somatostatin receptor number. These results suggest that glucose modulates the somatostatin receptor in the rat hippocampus. The physiological significance of these findings remains to be clarified.     

Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion

Animal models of ischemia are in wide use to elucidate the molecular mechanisms of brain injury that result from cardiovascular disease in humans. We have used the fluorescent, anionic dye, Fluoro-Jade, to examine cellular degeneration that occurs in association with the middle cerebral artery occlusion (MCAO) model. MCAO results in cortical infarction as well as damage to the hippocampus leading to a delayed form of death of hippocampal neurons. We examined brain sections at 6 h, 12 h, 1, 4, 7, 14 and 21 days after injury. Fluoro-Jade labeling of the striatum was seen over a protracted time-course, with degeneration beginning by 6 h after injury. Neuronal degeneration in the hippocampus, in contrast, occurs between 12 h and 7 days after injury with neuronal death reaching a peak at 4 days. GFAP/Fluoro-Jade double labeling revealed that the Fluoro-Jade positive staining at late time-points in the striatum included astrocytic cells. Together, the results show Fluoro-Jade to be a useful marker of cellular degeneration following ischemic injury. Further, the use of this dye has enabled us to demonstrate previously undescribed events of cellular injury resulting from ischemia.     

Beta-carboline interactions at the BZ-GABA receptor chloride-ionophore complex in the rat cerebral cortex

beta-Carboline congeners can act at the benzodiazepine (BZ) recognition site of the BZ-GABA receptor complex to increase GABA-stimulated chloride conductance (agonist effect), inhibit this conductance (inverse agonist effect) or block the actions of agonists and inverse agonists (antagonist effect). In this communication we describe the effects of several beta-carbolines (ZK 93423, ZK 91296, ZK 93426, and DMCM) on GABA-stimulated chloride influx into vesicles prepared from rat cerebral cortex. ZK 93423 produces an approximate 2-fold left-shift of the GABA dose-response curve at a concentration of 1.0 microM consistent with its full agonist activity (positive intrinsic efficacy), while the same concentration of ZK 91296 produces over a 1-fold left-shift consistent with its partial agonist activity. At higher concentrations (0.1 mM), ZK 91296 inhibits GABA-stimulated chloride influx which appears to be mediated through a non-BZ receptor mechanism since this effect is not reversed by the BZ antagonist ZK 93426. The augmenting effect of both ZK 93423 and ZK 91296 on GABA-stimulated chloride flux was reduced by the antagonist ZK 93426 in a dose-dependent manner and reached GABA-stimulated control levels at a ZK 93426 concentration of 1.0 microM. Interestingly, there was a further inhibition of the GABA-stimulated chloride influx at higher concentrations of ZK 93426 which is not seen when ZK 93426 is used in the absence of BZ agonists. The inverse agonist activity of DMCM was incompletely blocked by the antagonist ZK 93426. These data show that ZK 93426 can antagonize the effects of the full agonist ZK 93423 and partial agonist ZK 91296 at the BZ receptor. Furthermore, the interaction of the agonists with ZK 93426 results in the appearance of inverse agonist-like activity.(ABSTRACT TRUNCATED AT 250 WORDS)     

Opiate receptor localization in rat cerebral cortex

The differential distributions of [3H]naloxone-labeled and [3H]D-Ala-D-Leu-enkephalin-labeled opiate receptors in rat cerebral cortex were localized autoradiographically and quantified by grain counting and computerized densitometry. In addition, receptor distributions were compared to terminal patterns of thalamocortical projections labeled by axoplasmic transport of [3H]amino acids. Opiate receptors labeled with [3H]naloxone in a mu ligand selectivity pattern show striking laminar heterogeneity and are densest in limbic cortical areas, intermediate in the motor cortex, and fewest in the primary sensory areas. By contrast, opiate receptors labeled with [3H]D-Ala2-D-Leu5-enkephalin in a delta ligand selectivity pattern are much more homogeneously distributed across both regions and laminae within regions. Mu receptors in most cortical areas have density peaks in layers I and VI and each peak shows a density gradient that is sloped within the layer so that the highest densities are at the most superficial and the deepest portions of cortex. In addition, there is an intermediate peak whose laminar position varies depending on the area in which it is found. In rostral agranular cortex, including limbic and motor areas, the [3H]naloxone binding peaks are in layers I, III, and VI. In primary somatosensory cortex, the intermediate peak is in layer Va and in most of remaining homotypical cortex it is in layer IV. Some areas have only bilaminar labeling, in superficial and deep layers; these include portions of the sulcal and retrosplenial cortices. Piriform and entorhinal cortices have dense [3H]naloxone binding only in the deepest layer and show a descending gradient of density toward the superficial layer. The positions of the mu receptor peaks were compared with termination patterns of projections originating in the thalamus. Close correspondence was found between receptor binding in the prelimbic, primary somatosensory, and entorhinal areas and projection terminations arising from the thalamic mediodorsal, posterior, and central medial nuclei, respectively. Although regional variations in [3H]D-Ala2-D-Leu5-enkephalin-labeled receptor density are uncommon, a gradual decrease in the number of sites along the dorsomedial wall of the cortex from anterior cingulate to caudal retrosplenial limbic cortex can be observed. Laminar variations in binding density are small as well; higher concentrations of the peptide binding sites are usually found in the deep cortical layers. These findings emphasize aspects of opiate receptor architecture which may be relevant to identifying cortical "opiatergic" neurocircuitry and raise the possibility of opiate modulation of thalamocortical transmission.     

Benzodiazepine binding and interactions with the GABA receptor complex in living cultures of rat cerebral cortex

Benzodiazepines bind to living cultures of dissociated rat cerebral cortex. This binding is saturable, and kinetic analyses indicate that the binding is to a single class of sites with kinetic constants very close to those obtained using neuronal membrane preparations. The efficacy of a number of benzodiazepines, xanthine derivatives and other drugs in competition is similar to that seen in neuronal membrane preparations, and suggests that the benzodiazepine binding site studied in these investigations is the same as that found in neuronal membrane preparations and believed to be the pharmacologically active benzodiazepine binding site. GABA agonists increase the binding of benzodiazepines, and this increase has the same order of efficacy as their ability to hyperpolarize the neurons when applied at known concentrations with muscimol greater than GABA greater than THIP. At high concentrations THIP potentiate benzodiazepine binding to the same level as GABA. Diazepam increases the ability of both GABA and THIP to hyperpolarize the neurons as well as the amplitude of spontaneous IPSPs which, in this system, are GABA-mediated. The competitive GABA antagonist bicuculline methiodide slightly decreased benzodiazepine binding and also antagonized the increase due to GABA. The non-competitive GABA antagonist picrotoxinin had no effect on benzodiazepine binding but did antagonize the GABA-induced increase in benzodiazepine binding. Replacement of^Cl− in the incubation medium by acetate, which does not permeate the GABA-mediated Cl⁻ ionophore, increases benzodiapine binding, and GABA no longer increases the binding. Picrotoxinin decreases the increase in benzodiazepine binding is Cl⁻-free media, and this decrease is blocked by GABA. These results are discussed in terms of interactions at the GABA receptor complex consisting of a GABA recognition site, a benzodiazepine recognition site, a picrotoxinin recognition site, and a Cl⁻ ionophore.     

The effects of aging on muscarinic receptor/G-protein coupling in the rat hippocampus and striatum

In the striatum and hippocampus, there is a loss of sensitivity to muscarinic agonists with age which has been traced to events early in the signal transduction pathway. Our laboratory has therefore focussed on investigations at this level. The current experiments investigate the effects of age on G-protein/receptor interactions by using competitive binding assays to measure the ability of GppNHp to decrease the proportion of receptors bound to G-proteins in the absence and the presence of added Mg2+. L-[3H]Quinuclidinyl benzilate was used as a nonselective ligand and [3H]pirenzepine as an M1 selective ligand. We find that: (1) muscarinic receptors and G-proteins in the striatum appear to become loosely coupled with age, with no change in Mg2+ sensitivity. (2) M1-receptor/G-protein complexes in the hippocampus display increased sensitivity to the presence of Mg2+ with age, with those from old but not young tissue requiring added Mg2+ in order to uncouple. This effect, however, may not be M1 specific.     

Somatostatin facilitates the serotonin release from rat cerebral cortex, hippocampus and hypothalamus slices

The effect of somatostatin on the release of serotonin (5-HT) from the superfused slices of rat cerebral cortex, hippocampus and hypothalamus preloaded with [³H]5-HT was examined. Somatostatin (0.38–1.53 μM) was found to facilitate dose-dependently the electrically- or high K⁺-stimulated release of [³H]5-HT. The order of the stimulatory potency of somatostatin on the evoked release in the 3 areas of the brain was cortex,hippocampus>hypothalamus.     

Intrastriatal hypoxanthine administration affects Na,K-ATPase, acetylcholinesterase and catalase activities in striatum, hippocampus and cerebral cortex of rats

The aim of this study was to investigate the effects of a single intrastriatal injection of hypoxanthine, the major metabolite accumulating in Lesch-Nyhan disease, on Na(+),K(+)-ATPase, acetylcholinesterase and catalase activities in striatum, cerebral cortex and hippocampus of rats at different post-infusion periods. Adult Wistar rats were divided in two groups: (1) vehicle-injected group (control) and (2) hypoxanthine-injected group. For Na(+),K(+)-ATPase activity determination, the animals were sacrificed 3h, 24h and 7 days after drug infusion. For the evaluation of acetylcholinesterase and catalase activities, the animals were sacrificed 30min, 3h, 24h and 7 days after hypoxanthine infusion. Results show regional and time dependent effects of hypoxanthine on Na(+),K(+)-ATPase, acetylcholinesterase and catalase activities. The in vitro effect of hypoxanthine on the same enzymes in striatum was also investigated. Results showed that hypoxanthine inhibited Na(+),K(+)-ATPase, but not the activities of acetylcholinesterase and catalase in rat striatum. We suggest that these modification on cerebral biochemical parameters (Na(+),K(+)-ATPase, acetylcholinesterase and catalase activities) induced by intrastriatal administration of hypoxanthine in all cerebral structures studied, striatum, hippocampus and cerebral cortex, could be involved in the pathophysiology of Lesch-Nyhan disease.     

Glucose metabolism in the rat cerebral cortex in chronic hepatic failure with reference to glucose-derived amino acids

In order to investigate metabolic derangements in hepatic failure brains, glucose utilization was studied in regard to glucose-derived amino acids. For this purpose, chronic hepatic failure models were produced in adult male Wistar rats by successive carbontetrachloride injection (0.20 ml/100 g, B. W., twice/week) for 13 weeks. They were confirmed to develop chemical changes compatible with hepatic failure, showing markedly elevated serum levels of NH3, GOT and ALP. Animals were killed by decapitation during fasting and the brains were removed immediately. After the parietal cortical slices were incubated with D-(U-14C) glucose for 15 min, they were homogenized in 75% ethanol and deproteinized with water saturated chloroform. And the radioactivities of liberated CO2 and glucose-derived amino acids (glutamate, glutamine, aspartate, alanine and GABA) obtained from the supernatants were measured. In chronic hepatic failure brains as compared to normal controls, the amount of radioactivity of the two major metabolites, namely glutamate and CO2, decreased (p less than 0.01), but that of aspartate and alanine changed insignificantly, while GABA formation increased (p less than 0.05) and glutamine synthesis tended to increase. The above results indicate not only that the overall glucose oxidation in chronic hepatic failure brains declines reflecting low production of glutamate and CO2, but also that glucose-derived glutamate is actively metabolized through GABA shunt and energy-consuming ammonia fixation.     

Effects of entorhinal cortex lesion on learning behavior and on hippocampus in the rat

The initial stage of Alzheimer's disease is characterized by a neuropathological change in the entorhinal cortex. In a previous study it was shown that rats with excitotoxic lesion of entorhinal cortex showed an impaired acquisition of passive and active avoidance responses. In this study a rat with excitotoxic lesion of the entorhinal cortex was tested for ‘more operant’ behavioral learning (i.e., positive reinforcement operant learning). The hippocampus was also examined histologically as acetylcholinesterase-stained sections, and as synaptophysin immunostained sections and examined biochemically by liquid chromatography. Eight weeks after operation, the bilateral entorhinal cortex lesioned rats showed an impaired acquisition of positive reinforcement operant learning. The lesioned side of unilateral entorhinal cortex lesioned rats showed a decrease of acecylcholinesterase-positive fibers in the CA3, the dentate gyrus, and of synaptophysin-positive substances in the CA3. Biochemical study showed a decreased level of acetylcholine in the CA3, and in the dentate gyrus. The histological and biochemical findings are interpreted as indicating that the entorhinal cortex of the rat provides the major extrinsic synaptic input to the hippocampal formation via the circuit which serves as a relay passage through the dentate gyrus and via direct projections into the hippocampus. Behavioral findings confirmed the importance of the entorhinal cortex in memory acquisition and indicated that rats with a partial neuronal loss in the entorhinal cortex may be a useful model for the memory disturbance of Alzheimer's disease.     

Effects of noradrenaline depletion on adrenergic and muscarinic cholinergic receptors in the cerebral cortex, hippocampus, and cerebellum

The effects of noradrenaline depletion on α- and β-adrenergic and muscarinic cholinergic receptors in the cerebral cortex, hippocampus, and cerebellum of Wistar rats were studied. Noradrenaline depletion was obtained either by chemical (6-hydroxydopamine) lesions of the locus cerulet's or by chronic reserpine treatment. Two weeks after locus ceruleus lesions and 10 days after chronic reserpine treatment, the rats were killed and the cerebral cortex, hippocampus, and cerebellum dissected. A small portion of each tissue was assayed for noradrenaline, to assess the success of locus ceruleus lesions or reserpine treatment, and the remainder was used to measure the specific binding of tritiated α- and β-adrenergic and muscarinic cholinergic receptor ligands to particulate fractions of these tissues. The effect of noradrenaline depletion on isoproterenol-induced cyclic AMP generation in cerebellar slices was also studied. Noradrenaline depletion whether by locus ceruleus lesion or chronic reserpine treatment induced reproducible and significant increases in the binding to β-adrenergic receptors in the cerebral cortex and hippocampus. Scatchard analyses revealed that this increased binding was due to an increased density of β-adrenergic receptor binding sites. In the cerebellum, however, noradrenaline depletion did not result in an increase in β-adrenergic receptor binding nor in isoproterenol-induced cyclic AMP generation. Noradrenaline depletion did not cause significant changes in the binding characteristics of α-adrenergic or muscarinic cholinergic receptors in any of the three regions of the brain that were studied.     

Oxidative stress modulates Sir2alpha in rat hippocampus and cerebral cortex

Silent information regulator 2 (Sir2) helps survival and longevity in lower organisms during challenging situations. We investigated the possibility that Sir2alpha could be involved with brain plasticity under challenging situations. A diet high in saturated fat and sucrose, which has been shown in rodents to reduce synaptic plasticity and cognition, decreased Sir2alpha levels in the hippocampus and cerebral cortex, in proportion to an increase in protein oxidation. Vitamin E supplementation normalized, in the hippocampus and cerebral cortex, Sir2alpha levels that had been reduced by the high-fat diet. Neither the high-fat diet nor vitamin E supplementation affected cerebellar Sir2alpha. Vitamin E reduced, in the hippocampus, the oxidized nucleic acids that were increased by the high-fat diet. Western blot analysis showed higher contents of Sir2alpha in the hippocampus and cerebellum than in the cerebral cortex. Sir2alpha immunostaining was predominantly localized in the mossy fibre system and the dentate gyrus granule layer of the hippocampal formation. The high-fat diet decreased Sir2alpha immunostaining while vitamin E supplementation reversed these effects. Given that oxidative stress is a subproduct of dysfunctional energy homeostasis, we measured AMP-activated protein kinase (AMPK) to have an indication of the energy status of cells. Hippocampal levels of total and phosphorylated AMPK were reduced after high fat consumption and levels were normalized by vitamin E treatment. The present results show that oxidative stress and energy homeostasis associated with the consumption of the high-fat diet are critical for the regulation of Sir2alpha, with important implications for mechanisms of neural repair.     

Neuronal linkage of the cerebral cortex and the striatum

The striatum is the major input station of the basal ganglia. It receives a wide variety of inputs from all areas of the cerebral cortex. In particular, there are several parallel loop circuits, such as the motor, oculomotor, dorsolateral prefrontal, lateral orbitofrontal, and anterior cingulate loops, linking the frontal lobe and the basal ganglia. With respect to the motor loop, the motor-related areas, including the primary motor cortex, supplementary motor area, dorsal and ventral premotor cortices, presupplementary motor area, and rostral and caudal cingulate motor areas, send inputs to sectors of the putamen in combination via separate (parallel) and overlapping (convergent) pathways. Such signals return to the cortical areas of origin via the globus pallidus/substantia nigra and then the thalamus. The somatotopical representation is maintained in each structure that constitutes the motor loop. Employing retrograde transsynaptic transport of rabies virus, we have recently investigated the arrangement of multisynaptic pathways linking the basal ganglia to the caudal aspect of the dorsal premotor cortex (the so-called F2). F2r, the rostral sector of F2, has been shown to be involved in motor planning, whereas F2c, the caudal sector of F2, has been shown to be involved in motor execution. We analyzed the origins of multisynaptic inputs to F2r and F2c in the basal ganglia. Our results indicate that the 2 loop circuits connecting the F2r and F2c with the basal ganglia may possess a common convergent window at the input stage, while they have parallel divergent channels at the output stage.     

Effects of subacute lead exposure on [H]MK-801 binding in hippocampus and cerebral cortex in the adult rat

We used the NMDA receptor non-competitive antagonist, [³H]MK-801, as a ligand for an autoradiographic study to determine the effects of lead on NMDA receptor in the rat brain. Adult male rats were administered lead acetate, 100 mg/kg, or sodium acetate, 36 mg/kg (control), by i.p. for 7 days. High lead levels were detected in blood (41.1 μg/dl) and in brain (16.7–29.4 μg/g). Concentrations of lead in brain regions were not significantly different. The [³H]MK-801 binding was heterogeneously distributed throughout the rat brain with the following order of binding densities: hippocampal formation>cortex>caudate-putamen>thalamus>brainstem. Lead exposure produced a significant decrease in [³H]MK-801 binding to the NMDA receptor in the hippocampal formation including CA2 stratum radiatum, CA3 stratum radiatum, hilus dentate gyrus and presubiculum, and in the cerebral cortex including agranular insular, cingulate, entorhinal, orbital, parietal and perirhinal areas. The hippocampal formation is known as a critical neural structure for learning and memory processes, whereas, cortical and subcortical regions have been demonstrated to be involved in the modulation of complex behavioral processes. The NMDA receptor has been demonstrated to play a key role in synaptic plasticity underlying learning and memory. Lead-induced alterations of NMDA receptors in the hippocampal formation and cortical areas may play a role in lead-induced neurotoxicity.     

Endogenous GABA release from slices of rat cerebral cortex and hippocampus in vitro

Using a rapid, simple and sensitive radioreceptor assay, a Ca²⁺-dependent K⁺-evoked release of endogenous GABA was demonstrated from rat cortical and hippocampal slices in vitro. This evoked-release of endogenous GABA was similar to tha of [³H]GABA release (in its Ca²⁺ dependency) but differed from the latter in having a higher signal to noise level. Neither 5-HT nor a stable enkephalin analogue had any effect on endogenous GABA release from hippocampus slices.